Related Experiment Video
Updated: Jan 15, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Cortical lesions are common in a longitudinal progressive multifocal leukoencephalopathy cohort
Sarita Walvekar1,2, Riccardo Nistri1,3,4, Omar Al-Louzi1,5
1National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892, USA.
Abstract:
Progressive multifocal leukoencephalopathy (PML) cortical lesions have been noted on pathology but have not been studied in vivo. We aimed to characterize cortical lesions in PML and their clinical associations using in vivo MRI. Cortical lesions were identified by two independent raters on 3 tesla inversion-prepared T1-weighted MRI images from 44 participants enrolled in a PML natural history study, 10 healthy individuals and 5 HIV-infected individuals without PML. Follow-up imaging was evaluated for 10 participants with stable PML and 10 with worsening PML. Multiple sclerosis-related PML cases were excluded. In addition, cortical lesions identified on post-mortem 7T MRI from three individuals with PML were examined histopathologically. The primary outcome was the median number of cortical lesions per person. Secondary outcomes included change in lesion number and volume over time and associations between lesions and clinical measures. Cortical lesions were detected in 39/44 individuals with PML (median 6, range 0-136, interquartile range 16). No cortical lesions were identified in healthy or HIV-only participants. Cortical lesions identified on post-mortem MRI in 3 individuals with PML corresponded to areas of demyelination containing nuclei with immunoreactivity to JC virus Viral Protein 1 on histopathology. In 20 people with PML with follow-up evaluation (median follow-up interval 3 months, range 1-48, interquartile range 4), cortical lesion burden remained stable over time in both stable and worsening PML groups. There was no association between cortical lesion volume and cerebrospinal fluid viral load, survival, or cortical dysfunction signs. Cortical lesions are a common finding in PML and can be detected with 3 tesla MRI. Cortical lesions were not associated with distinct clinical characteristics and may form early in the disease with little subsequent expansion, providing insight into PML progression.
Insights
Cortical lesions are common in progressive multifocal leukoencephalopathy (PML) and detectable with MRI. These lesions, linked to demyelination, do not show clear clinical associations or significant expansion over time.
Area of Science:
- Neuroimaging
- Neuropathology
- Infectious Diseases
Background:
- Cortical lesions in progressive multifocal leukoencephalopathy (PML) have been observed pathologically but not studied in vivo.
- Understanding PML cortical lesions is crucial for characterizing disease progression and clinical impact.
Purpose of the Study:
- To characterize in vivo cortical lesions in PML using MRI.
- To investigate the clinical associations of these cortical lesions.
- To examine the histopathological basis of PML cortical lesions.
Main Methods:
- Utilized 3 tesla inversion-prepared T1-weighted MRI in 44 PML participants, 10 healthy controls, and 5 HIV-only individuals.
- Assessed lesion presence, number, and volume, with follow-up imaging for 20 PML patients.
- Correlated post-mortem MRI findings with histopathology, including JC virus VP1 immunoreactivity.
Main Results:
- Cortical lesions were detected in 39/44 (89%) PML participants, with a median of 6 lesions.
- No cortical lesions were found in healthy or HIV-only controls.
- Post-mortem MRI-histopathology confirmed lesions corresponded to demyelination with JC virus VP1.
- Lesion burden remained stable in follow-up evaluations for both stable and worsening PML.
- No significant association was found between cortical lesion volume and CSF viral load, survival, or cortical dysfunction.
Conclusions:
- Cortical lesions are a common finding in PML, detectable with 3 tesla MRI.
- These lesions appear to form early in PML and show limited expansion.
- Cortical lesion burden in PML is not associated with distinct clinical characteristics or outcomes.

